Activity
-
Check out our Exelixis volunteers’ recent events below: ◾ Joined our partners to swim and walk at the Women's Cancer Resource Center’s Swim a…
Check out our Exelixis volunteers’ recent events below: ◾ Joined our partners to swim and walk at the Women's Cancer Resource Center’s Swim a…
Liked by Lovell Abungan
-
In light of Exelixis's recent layoff, a number of employees have been impacted. As a way to help them expand their reach, I will be reposting their…
In light of Exelixis's recent layoff, a number of employees have been impacted. As a way to help them expand their reach, I will be reposting their…
Liked by Lovell Abungan
-
We’ve appointed Amy Peterson, M.D., as our new Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer. Read more:…
We’ve appointed Amy Peterson, M.D., as our new Executive Vice President, Product Development & Medical Affairs, and Chief Medical Officer. Read more:…
Liked by Lovell Abungan
Experience & Education
-
Exelixis
View Lovell’s full experience
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
More activity by Lovell
-
Published in Nature Medicine: NIBR researchers share data from preclinical development and a first-in-human, phase 1 study of an investigational…
Published in Nature Medicine: NIBR researchers share data from preclinical development and a first-in-human, phase 1 study of an investigational…
Liked by Lovell Abungan
-
Our team enjoyed green juice last week to support healthy eating habits during #LiverCancerAwarenessMonth!
Our team enjoyed green juice last week to support healthy eating habits during #LiverCancerAwarenessMonth!
Liked by Lovell Abungan
-
We look forward to sharing our latest research with oncologists and industry experts at #ESMO22.
We look forward to sharing our latest research with oncologists and industry experts at #ESMO22.
Liked by Lovell Abungan
-
We announced our Q2 2022 earnings results. Details available here: https://bit.ly/3bMDeL0.
We announced our Q2 2022 earnings results. Details available here: https://bit.ly/3bMDeL0.
Liked by Lovell Abungan
-
In 2021, Exelixis had over 300 new hires and we’re still growing! We employ the best in biotech to discover, develop and commercialize medicines that…
In 2021, Exelixis had over 300 new hires and we’re still growing! We employ the best in biotech to discover, develop and commercialize medicines that…
Liked by Lovell Abungan
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Lovell Abungan
2 others named Lovell Abungan are on LinkedIn
See others named Lovell Abungan